168 related articles for article (PubMed ID: 33572758)
1. The Expression of the Cancer-Associated lncRNA
Pensold D; Gehrmann J; Pitschelatow G; Walberg A; Braunsteffer K; Reichard J; Ravaei A; Linde J; Lampert A; Costa IG; Zimmer-Bensch G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572758
[TBL] [Abstract][Full Text] [Related]
2. EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter.
Yildiz CB; Kundu T; Gehrmann J; Koesling J; Ravaei A; Wolff P; Kraft F; Maié T; Jakovcevski M; Pensold D; Zimmermann O; Rossetti G; Costa IG; Zimmer-Bensch G
Epigenetics Chromatin; 2023 Oct; 16(1):42. PubMed ID: 37880732
[TBL] [Abstract][Full Text] [Related]
3. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.
Bhatia S; Hirsch K; Baig NA; Rodriguez O; Timofeeva O; Kavanagh K; Lee YC; Wang XJ; Albanese C; Karam SD
J Hematol Oncol; 2015 Sep; 8():105. PubMed ID: 26345456
[TBL] [Abstract][Full Text] [Related]
4. SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF.
Saeinasab M; Bahrami AR; González J; Marchese FP; Martinez D; Mowla SJ; Matin MM; Huarte M
J Exp Clin Cancer Res; 2019 Apr; 38(1):172. PubMed ID: 31014355
[TBL] [Abstract][Full Text] [Related]
5. Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
Jukonen J; Moyano-Galceran L; Höpfner K; Pietilä EA; Lehtinen L; Huhtinen K; Gucciardo E; Hynninen J; Hietanen S; Grénman S; Ojala PM; Carpén O; Lehti K
Sci Rep; 2021 Apr; 11(1):8856. PubMed ID: 33893375
[TBL] [Abstract][Full Text] [Related]
6. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.
Sikkema AH; den Dunnen WF; Hulleman E; van Vuurden DG; Garcia-Manero G; Yang H; Scherpen FJ; Kampen KR; Hoving EW; Kamps WA; Diks SH; Peppelenbosch MP; de Bont ES
Neuro Oncol; 2012 Sep; 14(9):1125-35. PubMed ID: 22723427
[TBL] [Abstract][Full Text] [Related]
7. Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma.
Wang TH; Ng KF; Yeh TS; Wang YL; Liang KH; Yeh CT; Chen TC
PLoS One; 2012; 7(7):e41749. PubMed ID: 22860012
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Gene; 2019 Jul; 705():44-50. PubMed ID: 30981837
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p.
Li M; Bian Z; Jin G; Zhang J; Yao S; Feng Y; Wang X; Yin Y; Fei B; You Q; Huang Z
Cancer Med; 2019 May; 8(5):2404-2413. PubMed ID: 30945457
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
11. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
12. EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.
Li JJ; Liu DP; Liu GT; Xie D
Oncogene; 2009 Apr; 28(15):1759-68. PubMed ID: 19270726
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Urothelial Carcinoma Associated 1 Inhibits the Proliferation and Migration of Medulloblastoma Cells.
Zhengyuan X; Hu X; Qiang W; Nanxiang L; Junbin C; Wangming Z
Med Sci Monit; 2017 Sep; 23():4454-4461. PubMed ID: 28916736
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines.
Bonfim-Silva R; Ferreira Melo FU; Thomé CH; Abraham KJ; De Souza FAL; Ramalho FS; Machado HR; De Oliveira RS; Cardoso AA; Covas DT; Fontes AM
Int J Oncol; 2017 Dec; 51(6):1929-1940. PubMed ID: 29039487
[TBL] [Abstract][Full Text] [Related]
15. EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability.
Wang TH; Chang JL; Ho JY; Wu HC; Chen TC
FEBS J; 2012 Jan; 279(2):251-63. PubMed ID: 22074469
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
Kong Q; Qiu M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.
Jiang H; Li T; Qu Y; Wang X; Li B; Song J; Sun X; Tang Y; Wan J; Yu Y; Zhan J; Zhang H
Cancer Lett; 2018 Jul; 425():78-87. PubMed ID: 29604394
[TBL] [Abstract][Full Text] [Related]
19. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
Dai W; Dai JL; Tang MH; Ye MS; Fang S
World J Gastroenterol; 2019 Oct; 25(38):5789-5799. PubMed ID: 31636472
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
Sun XH; Fan WJ; An ZJ; Sun Y
Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
